Freek de Haan

Statistics

Publications

Citations

H-Index

Active since

2021

Affiliations

Mahidol Oxford Tropical Medicine Research Unit(Current)

Freek de Haan is an author at Mahidol Oxford Tropical Medicine Research Unit specializing in artemisinin resistance, pharmacology, and clinical pharmacology.

ORCID

Publications per year

2021–2022

Publications

Deploying triple artemisinin-based combination therapy (TACT) for malaria treatment in Africa: ethical and practical considerations

Paulina Tindana, Freek de Haan, Chanaki Amaratunga et al. · Malaria Journal · 2021 · 31 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

Market Formation in a Global Health Transition

Freek de Haan, Ellen H.M. Moors, Arjen M. Dondorp et al. · Environmental Innovation and Societal Transitions · 2021 · 21 citations · Full text

Management, Health Policy, Innovation Management +16

To what extent are the antimalarial markets in African countries ready for a transition to triple artemisinin-based combination therapies?

Freek de Haan, Oladimeji Akeem Bolarinwa, Rosemonde Guissou et al. · PLoS ONE · 2021 · 11 citations · Full text

Pharmacy, Pharmaceutical Policy, Pharmacology +16

Ethical considerations in deploying triple artemisinin-based combination therapies for malaria: An analysis of stakeholders’ perspectives in Burkina Faso and Nigeria

Paulina Tindana, Rosemonde Guissou, Oladimeji Akeem Bolarinwa et al. · PLoS ONE · 2022 · 11 citations · Full text

Public Health, Health Policy, Public Health Ethics +15

Expert perspectives on the introduction of Triple Artemisinin-based Combination Therapies (TACTs) in Southeast Asia: a Delphi study

Freek de Haan, Wouter Boon, Chanaki Amaratunga et al. · BMC Public Health · 2022 · 10 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

1–5 of 5